Earliest functional declines in Huntington disease

被引:113
作者
Beglinger, Leigh J. [1 ]
O'Rourke, Justin J. F. [2 ]
Wang, Chiachi [1 ]
Langbehn, Douglas R. [1 ]
Duff, Kevin [1 ]
Paulsen, Jane S. [1 ,3 ,4 ]
机构
[1] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Counselling Psychol, Iowa City, IA 52242 USA
[3] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA
[4] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA
基金
美国国家卫生研究院;
关键词
Neuropsychological assessment; Depression; Daily functioning; Occupation; ADLs (activities of daily living); DIAGNOSIS; CONTRIBUTE;
D O I
10.1016/j.psychres.2010.04.030
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
We examined the gold standard for Huntington disease (HD) functional assessment, the Unified Huntington's Disease Rating Scale (UHDRS), in a group of at-risk participants not yet diagnosed but who later phenoconverted to manifest HD. We also sought to determine which skill domains first weaken and the clinical correlates of declines. Using the UHDRS Total Functional Capacity (TFC) and Functional Assessment Scale (FAS), we examined participants from Huntington Study Group clinics who were not diagnosed at their baseline visit but were diagnosed at a later visit (N = 265). Occupational decline was the most common with 65.1% (TFC) and 55.6% (FAS) reporting some loss of ability to engage in their typical work. Inability to Manage finances independently (TFC 49.2%, FAS 35.1%) and drive Safely (FAS 33.5%) were also found. Functional decline was significantly predicted by motor, cognitive, and depressive symptoms. The UHDRS captured early functional losses in individuals with HD prior to formal diagnosis, however, fruitful areas for expanded assessment of early functional changes are performance at work, ability to manage finances, and driving. These are also important areas for clinical monitoring and treatment planning as up to 65% experienced loss in at least one area prior to diagnosis. (C) 2010 Published by Elsevier Ireland Ltd.
引用
收藏
页码:414 / 418
页数:5
相关论文
共 19 条
[1]  
[Anonymous], 1978, PSYCHOL ASSESSMENT R
[2]  
[Anonymous], NEUROPSY NEUROPSY BE
[3]  
Bren Linda, 2006, FDA Consum, V40, P26
[4]   Behavioural abnormalities contribute to functional decline in Huntington's disease [J].
Hamilton, JM ;
Salmon, DP ;
Corey-Bloom, J ;
Gamst, A ;
Paulsen, JS ;
Jerkins, S ;
Jacobson, MW ;
Peavy, G .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (01) :120-122
[5]   Interrater agreement in the assessment of motor manifestations of Huntington's disease [J].
Hogarth, P ;
Kayson, E ;
Kieburtz, K ;
Marder, K ;
Oakes, D ;
Rosas, D ;
Shoulson, I ;
Wexler, NS ;
Young, AB ;
Zhao, HW .
MOVEMENT DISORDERS, 2005, 20 (03) :293-297
[6]   Unified Huntington's disease rating scale: Reliability and consistency [J].
Kieburtz, K ;
Penney, JB ;
Como, P ;
Ranen, N ;
Shoulson, I ;
Feigin, A ;
Abwender, D ;
Greenamyre, JT ;
Higgins, D ;
Marshall, FJ ;
Goldstein, J ;
Steinberg, K ;
Shih, C ;
Richard, I ;
Hickey, C ;
Zimmerman, C ;
Orme, C ;
Claude, K ;
Oakes, D ;
Sax, DS ;
Kim, A ;
Hersch, S ;
Jones, R ;
Auchus, A ;
Olsen, D ;
BisseyBlack, C ;
Rubin, A ;
Schwartz, R ;
Dubinsky, R ;
Mallonee, W ;
Gray, C ;
Godfrey, N ;
Suter, G ;
Shannon, KM ;
Stebbins, GT ;
Jaglin, JA ;
Marder, K ;
Taylor, S ;
Louis, E ;
Moskowitz, C ;
Thorne, D ;
Zubin, N ;
Wexler, N ;
Swenson, MR ;
Paulsen, J ;
Swerdlow, N ;
Albin, R ;
Wernette, C ;
Walker, F ;
Hunt, V .
MOVEMENT DISORDERS, 1996, 11 (02) :136-142
[7]   Predictors of diagnosis in Huntington disease [J].
Langbehn, Douglas R. ;
Paulsen, Jane S. .
NEUROLOGY, 2007, 68 (20) :1710-1717
[8]   Evidence for specific cognitive deficits in preclinical Huntington's disease [J].
Lawrence, AD ;
Hodges, JR ;
Rosser, AE ;
Kershaw, A ;
Ffrench-Constant, C ;
Rubinsztein, DC ;
Robbins, TW ;
Sahakian, BJ .
BRAIN, 1998, 121 :1329-1341
[9]   A NOVEL GENE CONTAINING A TRINUCLEOTIDE REPEAT THAT IS EXPANDED AND UNSTABLE ON HUNTINGTONS-DISEASE CHROMOSOMES [J].
MACDONALD, ME ;
AMBROSE, CM ;
DUYAO, MP ;
MYERS, RH ;
LIN, C ;
SRINIDHI, L ;
BARNES, G ;
TAYLOR, SA ;
JAMES, M ;
GROOT, N ;
MACFARLANE, H ;
JENKINS, B ;
ANDERSON, MA ;
WEXLER, NS ;
GUSELLA, JF ;
BATES, GP ;
BAXENDALE, S ;
HUMMERICH, H ;
KIRBY, S ;
NORTH, M ;
YOUNGMAN, S ;
MOTT, R ;
ZEHETNER, G ;
SEDLACEK, Z ;
POUSTKA, A ;
FRISCHAUF, AM ;
LEHRACH, H ;
BUCKLER, AJ ;
CHURCH, D ;
DOUCETTESTAMM, L ;
ODONOVAN, MC ;
RIBARAMIREZ, L ;
SHAH, M ;
STANTON, VP ;
STROBEL, SA ;
DRATHS, KM ;
WALES, JL ;
DERVAN, P ;
HOUSMAN, DE ;
ALTHERR, M ;
SHIANG, R ;
THOMPSON, L ;
FIELDER, T ;
WASMUTH, JJ ;
TAGLE, D ;
VALDES, J ;
ELMER, L ;
ALLARD, M ;
CASTILLA, L ;
SWAROOP, M .
CELL, 1993, 72 (06) :971-983
[10]   Rate of functional decline in Huntington's disease [J].
Marder, K ;
Zhao, H ;
Myers, RH ;
Cudkowicz, M ;
Kayson, E ;
Kieburtz, K ;
Orme, C ;
Paulsen, J ;
Penney, JB ;
Siemers, E ;
Shoulson, I .
NEUROLOGY, 2000, 54 (02) :452-458